在餐饮文化日益丰富的今天，如何让国民从"吃得美味"转向"吃得健康"？答案或许藏在厨房的"源 头"——厨师。2025年，由北京市于若木慈善基金会与华彬文化基金会主办的"健康中国行·食育进校 园"项目实现战略深化，将目光投向职业院校烹饪专业学生，通过"为梦想加油"食育推广系列公益活 动，为行业培育了一批兼具技艺、营养知识与文化自信的"火种"。 实践营闭营仪式 讲座现场 实践营研学现场 今年，项目将多年实践成果编纂成册，形成《营养健康与饮食文化》培训教材，并捐赠予四川、贵州、 重庆等地4所职业院校，惠及师生数万名。 "我们意识到，未来的厨师不仅是美味的创造者，更应是国民健康的守门人。"项目负责人表示，"赋能 他们，就等于从源头为亿万家庭的餐桌健康上了保险。"这一战略转向，体现了项目的前瞻性与对健康 中国战略的深层理解。 创新闭环：构建"学-思-践-悟"成长阶梯 "为梦想加油"项目成功打造了一个层层递进、闭环运行的育人模型。它以"营养烹饪与饮食文化"系列专 题讲座奠定理论基础，邀请中国农业大学、国家食品安全风险评估中心等机构的权威专家，系统讲授膳 食营养、食品安全与饮食文化知识。继而，以"食育文化公益实践营"作为升华 ...

肇庆剑指"中国 南药食养之 都"，底气和雄 心何在？_南方 +_南方plus 近日，一场国家 级南药食养产业 大会在肇庆圆满 落幕，八方宾朋 齐聚这座岭南名 城，共同见证南 药食养产业的蓬 勃发展。这场盛 会不仅是对肇庆 南药产业地位的 肯定，更是一声 集结号，吹响了 肇庆打造"中国 南药食养之 都"的冲锋号。 这场高规格大会 的落地并非偶 然。作为粤港澳 大湾区的重要节 点城市，肇庆凭 借什么吸引国家 级产业大会的目 光？ 示，肇庆南药种 植面积达156.6 万亩，总产量66 万吨，总产值超 100亿元。形成 了多个规模化、 北回归线黄金气 候带，森林覆盖 率达70%以上， 是南药生长的天 然沃土。广佛 手、广藿香、巴 戟天、何首乌、 肉桂、肇实等6 种道地药材先后 纳入《广东省岭 南中药材保护条 例》。数据显 答案在于这座城 市与南药深厚的 渊源、坚实的产 业基础以及把握 健康中国战略机 遇的远见。大会 留下的不仅是行 业交流的余温， 更是肇庆南药产 业迈向新征程的 契机。 底气源于丰厚的 家底。肇庆地处 标准化种植基 地。 从地理区位看， 肇庆作为大湾区 连接大西南的枢 纽城市，既可承 接大湾区科技创 ...

医务社会工作者，是医患的"连心桥"，也是医疗环节间的"黏合剂"。 除了各大医院，医务社工的身影，还活跃在社区里，随时陪伴在居民身边。 "最近几年，您变得爱忘事儿了吗？"看似家常聊天的话题，其实是北京市脑健康体检的测试题。在海淀 区上庄镇社区卫生服务中心的医务社工科，这样的"小测试"每天都在进行。住在附近的老人来到社区， 在医务社工的帮助下进行认知功能筛查。 不久前，一名七旬老人做完一年一度的免费健康体检后，打算放弃认知筛查，这时，医务社工的优势就 发挥出来了，"别担心，万一真有'苗头'，咱们及时干预就能控制和延缓发展。"在社工耐心的引导下， 老人完成了测试，并在初筛结果提示异常的情况下，通过医联体绿色通道转诊至北京老年医院，接受了 进一步的检查和诊疗。大医院和社区医院联手治疗、干预后，老人的症状已经明显好转。 市卫健委介绍，目前本市已形成"以基层为重点、三级医院引领、二级医院支撑、各级医疗机构协同推 进"的发展体系。同时，16个区和经开区的社区卫生服务中心已全面开展医务社会工作。不久前，本市 还启动了"双工联动双向赋能健康社区"的服务项目，推动医务社工联手社区社工，共同将服务从医疗机 构延伸至社会治理末梢，打 ...

中国深圳，在大沙河即将汇入深圳湾处，水面倒映着南山粤海街道的天际线。河畔，迈瑞医疗总部大厦 静静伫立，如同一位沉稳的水手，见证着"中国制造"向"中国智造"转型升级的磅礴浪潮。如今，迈瑞医 疗奔向更广阔的水域——11月10日晚间，迈瑞医疗发布公告称，公司已于当日向香港联交所递交了发行 境外上市外资股（H股）并在香港联交所主板挂牌上市的申请。 在李西廷看来，与之前两次上市不同，迈瑞医疗此次赴港上市有着深刻的战略考量。回顾过往：2006 年，迈瑞成功赴美上市，募资2.7亿美元，成为中国首家在美股上市的医疗器械企业，初步拓展了全球 渠道；2018年回归A股，募资约60亿元，创下当时创业板最大IPO纪录。 李西廷称，此次选择赴香港上市，是多重因素综合考量的结果：首先，香港作为国际金融中心，其资本 市场更加国际化，有利于提升公司在国际市场的品牌形象和信任度；其次，国际资本加持将为公司全球 化布局提供更便捷的融资平台；此外，香港市场的灵活激励机制有助于吸引国际顶尖人才。 "要在国际市场发展，没有国际资本的加持，国际化是不完整的。"李西廷认为，特别是在当前全球环境 下，香港资本市场展现出更强韧性。近期，国际资金持续流入香港市 ...

Core Insights - The eighth China International Import Expo (CIIE) concluded with a record intended transaction amount of $83.49 billion, marking a 4.4% increase from the previous year [1][3]. Group 1: Scale and Participation - The CIIE featured participation from 155 countries, regions, and international organizations, with 4,108 foreign enterprises exhibiting, covering an exhibition area of over 430,000 square meters, setting a new scale record [5][16]. - The event showcased a significant increase in participation from least developed countries, with an 80% rise in African enterprises, highlighting the inclusion of niche agricultural products [8][16]. Group 2: Innovation and Technology - The expo displayed advancements in robotics, with humanoid robots showcasing enhanced capabilities, indicating the continuous evolution of the event [10][11]. - A total of 461 new products, technologies, and services were presented, reflecting the event's commitment to innovation and quality [14][16]. Group 3: Economic Impact and Global Integration - The CIIE serves as a vital platform for international trade, demonstrating China's growing market attractiveness, with over 600 new exhibitors compared to the previous year, including 290 Fortune 500 companies [16][18]. - The event emphasizes China's role as a significant contributor to global economic stability, with a GDP growth rate of 5.2% in the first three quarters of the year [25][23].

Core Viewpoint - The first National South Medicine Food and Health Conference will be held in Zhaoqing, Guangdong from November 19 to 21, 2025, focusing on the development of the South medicine industry and promoting high-quality growth in this sector [3][12][59]. Group 1: Conference Overview - The conference is organized by the South Subtropical Crop Center of the Ministry of Agriculture and Rural Affairs, in collaboration with the Guangdong Provincial Department of Agriculture and Rural Affairs and the Zhaoqing Municipal Government [2][3]. - It aims to create a national platform for discussion and cooperation in the South medicine food and health industry, which has previously lacked a centralized forum [12][14]. - The theme of the conference is "Big Food Concept Leading Big Health, Food and Medicine Homologous Promoting Rural Revitalization," focusing on high-quality development, product innovation, and the integration of traditional Chinese medicine culture with modern health consumption [14][17]. Group 2: Key Highlights - The conference will showcase Zhaoqing's unique medicinal resources, emphasizing its status as a core production area for South medicine, with a total planting area of 1.5662 million acres and a total output of 659,900 tons in 2024, generating a total output value of 10.605 billion yuan [24][23]. - Various activities will be organized, including product exhibitions, thematic discussions, and immersive experiences to promote industry exchange and innovation [30][31]. - Notable experts from the fields of traditional Chinese medicine and health industries will present at the opening ceremony, discussing topics such as the development prospects of food and medicine homologous substances and sustainable utilization of South medicine resources [33][36]. Group 3: Industry Development - The conference aims to integrate government, industry, academia, research, and application to address challenges in the South medicine industry, optimizing resource allocation and accelerating the transformation of scientific research achievements [18][20]. - It will also release several key documents, including the "Guangdong South Medicine Food and Health Exploration Map" and the "Zhaoqing Cinnamon Industry Development White Paper," to help businesses find markets and set industry standards [37][43]. - The event is expected to serve as a bridge connecting the past and future of the South medicine industry, enhancing public understanding and recognition of South medicine, and contributing to the health of the nation and rural revitalization [58][60].

Core Viewpoint - Lung cancer remains one of the leading malignancies in terms of incidence and mortality in China, necessitating a focus on early detection, diagnosis, and treatment to improve cure rates and reduce mortality [1][2] Group 1: Project Overview - The "Lung Health Guardian" project was officially launched during the 8th China International Import Expo, focusing on early prevention and treatment of lung cancer [1] - The project aims to provide integrated public medical services, including screening, diagnosis, and treatment, specifically targeting high-risk groups such as outdoor workers [1] Group 2: Implementation and Support - The project will utilize advanced low-dose spiral CT equipment for rapid and accurate lung imaging checks for participants [1] - In cases where abnormalities are detected during screening, a green channel will be activated for multidisciplinary consultations involving experts from Shanghai United Family Hospital and related partners [1] - The project will employ advanced minimally invasive surgical techniques to aid patient recovery [1] Group 3: Financial and Social Responsibility - For patients requiring surgical intervention and meeting assistance criteria, the Beijing United Family Medical Assistance Foundation will provide medical aid, while ZhiGuan FuXing will donate related surgical materials to alleviate the financial burden on beneficiaries [2] - The project is a significant step for United Family Healthcare in fulfilling its social responsibility and aims to leverage its expertise and technological advantages to benefit those in need [2]

Core Viewpoint - The "Jinzhou Health Care Master" brand training program marks a significant step in talent cultivation for the health care industry in Qiannan, injecting new momentum into the local economy and employment opportunities [2][3][30]. Group 1: Training Program Details - The first phase of the "Jinzhou Health Care Master" brand demonstration training class commenced on November 4, 2023, at Qiannan National Vocational and Technical College [2]. - The training focuses on intermediate elderly care knowledge and covers five major health care industry modules: cultural tourism, leisure vacation, outdoor sports, food and medicine, and medical care [3][4]. - The program consists of two phases, training a total of 100 participants with a 100% employment rate upon completion [6]. Group 2: Regional Advantages and Collaboration - Qiannan is the only city in China awarded the title of "China's Four Seasons Health Care Capital," benefiting from unique ecological resources [8][15]. - The collaboration between Guangdong's Huizhou City and Guizhou's Qiannan aims to leverage regional resource advantages, creating a labor brand centered on "Guangdong Market + Guizhou Resources" [10][11]. - The "Jinzhou Health Care Master" brand has been recognized at the municipal level, training 2,800 certified health care workers and facilitating employment for 7,500 individuals, with 80% being poverty alleviation labor [17][18]. Group 3: Industry Impact and Future Prospects - The establishment of a mature health care industry system in Qiannan includes 105 health care projects and 33 bases, leading to stable job demand [22]. - The "Jinzhou Health Care Master" is expected to become a core talent supply source in Southwest China, offering specialized care that utilizes ecological resources and cultural techniques [23][24]. - The program has gained market recognition and media attention, enhancing service quality and economic benefits, thus contributing to the rural revitalization strategy and providing essential talent support for the health care industry's upgrade and high-quality development [29][30][31]. Group 4: Future Development Plans - Future efforts will focus on deepening the East-West cooperation mechanism and expanding employment channels for Guizhou workers in the Guangdong-Hong Kong-Macao Greater Bay Area and Yangtze River Delta regions [32][34].

Core Viewpoint - The pharmaceutical industry should actively integrate into the national development framework and align its growth with the Healthy China strategy, emphasizing innovation and social responsibility [3][4]. Group 1: Integration with National Strategy - The company has consistently aligned its development with national strategies over the past 32 years, establishing a comprehensive quality control system from raw material cultivation to intelligent production [3]. - The integration of AI in the production process, particularly in intelligent filling of injections, and the establishment of a quality traceability system throughout the product lifecycle exemplify the fusion of standardization and intelligence [3]. Group 2: R&D Innovation - The industry is encouraged to focus on theoretical innovation and deepen collaboration between academia and research, advocating for increased R&D investment [3]. - A tiered R&D system is recommended, involving simultaneous production, storage, development, and conceptualization, particularly in key disease areas to foster a patent network [3]. Group 3: Equitable Healthcare Development - Pharmaceutical companies should engage in building inclusive healthcare by sending experts to grassroots levels, providing medical assistance, and training local healthcare personnel [3]. - An innovative model combining "enterprise + base + farmers" is suggested to ensure the quality of traditional Chinese medicine while promoting employment and achieving a positive interaction between health support and industrial development [3]. Group 4: Future Outlook - The industry should intensify efforts in tackling key core technologies and promote the collaborative development of traditional Chinese medicine, chemical drugs, and biological drugs [4]. - Companies are advised to incorporate social responsibility into their development strategies and establish sustainable public welfare mechanisms to enhance their value while contributing to the Healthy China initiative [4].

Core Viewpoint - The company, Zhonghui Mutual Insurance, has demonstrated significant growth and profitability through its unique mutual insurance model, aligning with national health strategies and promoting inclusive finance [1][2]. Business Performance - As of the third quarter of 2025, Zhonghui Mutual Insurance achieved a premium income of 358,169.89 million yuan, reflecting steady growth and a strong alignment with market demands [2]. - The company exhibits a three-dimensional positive trend characterized by stable premiums, robust profitability, and quality optimization [2]. Growth Drivers - The growth is driven by a dual strategy of underwriting and investment, focusing on the health insurance segment and developing specialized products for patients with pre-existing conditions [3]. - The company has launched over 100 exclusive products targeting specific health issues, filling significant market gaps [3]. Digital Transformation - Zhonghui Mutual has advanced its digital operations by implementing various projects such as data warehouses and AI-driven platforms, enhancing service efficiency and customer experience [4]. - The company has achieved a nearly 95% online reporting rate and a 99% case closure rate within one day, significantly improving claims processing [4]. Policy Response - The company is actively responding to regulatory initiatives aimed at enhancing health insurance services, particularly for patients with chronic conditions [4][5]. - As of September 30, 2025, health insurance accounted for over 96.3% of the company's premium income, demonstrating its commitment to being a true health insurance provider [5]. Product Development - Zhonghui Mutual has developed a comprehensive range of insurance products for chronic kidney disease patients, addressing significant coverage gaps in the market [5][6]. - The company has also introduced innovative health management services that improve patient outcomes and reduce healthcare costs [6][7]. Ecosystem Approach - The company has created a holistic ecosystem for chronic disease management, integrating insurance coverage with healthcare services to enhance patient care [7]. - Zhonghui Mutual's initiatives in liver disease insurance further exemplify its commitment to comprehensive health management and patient support [7]. Mechanism Advantages - The mutual insurance model provides a sustainable framework for inclusive finance, focusing on the needs of specific groups such as the elderly and chronic disease patients [8][9]. - The company has established a governance structure that allows member participation in decision-making, enhancing service quality and member satisfaction [9]. Future Outlook - With the ongoing implementation of inclusive insurance policies and the "Healthy China" strategy, Zhonghui Mutual aims to continue its path of inclusive development and create more value for its members [9].